MedTech Acquisition Co. (OTCMKTS:MTACU – Get Free Report) traded up 19.5% during mid-day trading on Thursday . The stock traded as high as $11.35 and last traded at $11.35. 1,900 shares traded hands during trading, an increase of 225% from the average session volume of 585 shares. The stock had previously closed at $9.50.
MedTech Acquisition Stock Up 19.5%
The business’s fifty day simple moving average is $11.35 and its two-hundred day simple moving average is $11.35.
About MedTech Acquisition
MedTech Acquisition Corporation is a special purpose acquisition company formed in 2021 under the laws of Delaware and listed on the OTC Markets. The company’s primary objective is to complete a business combination with one or more businesses in the medical technology or life sciences sectors. By structuring as a blank check company, MedTech Acquisition seeks to leverage public market capital and strategic support to accelerate growth in a highly innovative industry.
MedTech Acquisition targets companies operating in areas such as diagnostic imaging, minimally invasive devices, regenerative medicine and digital health.
Further Reading
- Five stocks we like better than MedTech Acquisition
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for MedTech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedTech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
